About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Non-small Cell Lung Cancer Study US75 (Z-PACT)

NCT00086268·80 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Novartis Pharmaceuticals

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Male or Female patients at least of 18 years old
Patients with diagnosed non-small cell lung cancer that cannot be treated by surgery
Women must not be pregnant or attempting to become pregnant
Able and willing to sign informed consent

You may not be if

Patients with cancer that has spread to the bone
Patients with cancer that has spread to the brain who are receiving treatment
Patients with kidney disease
Patients treated with other investigational drugs

The record

StatusCompleted

PhasePhase 3

Taking part250

StartedApr 2004

UpdatedSep 13, 2017

Conditions

Non Small Cell Lung Carcinoma

Where80

Clinical Research Consultants
Hoover, Alabama, United States
Arizona Oncology Assoc.
Tucson, Arizona, United States
NEA Clinic
Jonesboro, Arkansas, United States

Clareo Health | Non-small Cell Lung Cancer Study US75 (Z-PACT)